These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
202 related items for PubMed ID: 17380000
1. Failure of treatment with anti-VEGF monoclonal antibody for long-standing POEMS syndrome. Kanai K, Kuwabara S, Misawa S, Hattori T. Intern Med; 2007; 46(6):311-3. PubMed ID: 17380000 [Abstract] [Full Text] [Related]
11. Treatment of POEMS syndrome with bevacizumab. Samaras P, Bauer S, Stenner-Liewen F, Steiner R, Zweifel M, Renner C, Knuth A. Haematologica; 2007 Oct 15; 92(10):1438-9. PubMed ID: 18024383 [Abstract] [Full Text] [Related]
12. Safety and efficacy of thalidomide in patients with POEMS syndrome: a multicentre, randomised, double-blind, placebo-controlled trial. Misawa S, Sato Y, Katayama K, Nagashima K, Aoyagi R, Sekiguchi Y, Sobue G, Koike H, Yabe I, Sasaki H, Watanabe O, Takashima H, Nishizawa M, Kawachi I, Kusunoki S, Mitsui Y, Kikuchi S, Nakashima I, Ikeda S, Kohara N, Kanda T, Kira J, Hanaoka H, Kuwabara S, Japanese POEMS Syndrome for Thalidomide (J-POST) Trial Study Group. Lancet Neurol; 2016 Oct 15; 15(11):1129-37. PubMed ID: 27496680 [Abstract] [Full Text] [Related]
13. Thalidomide reduces serum VEGF levels and improves peripheral neuropathy in POEMS syndrome. Kuwabara S, Misawa S, Kanai K, Sawai S, Hattori T, Nishimura M, Nakaseko C. J Neurol Neurosurg Psychiatry; 2008 Nov 15; 79(11):1255-7. PubMed ID: 18469028 [Abstract] [Full Text] [Related]
14. Does suppression of VEGF alone lead to clinical recovery in POEMS syndrome? Arimura K. J Neurol Neurosurg Psychiatry; 2013 Dec 15; 84(12):1301. PubMed ID: 23644502 [No Abstract] [Full Text] [Related]
15. Correlation of changes in serum level of VEGF and peripapillary retinal thickness in patients with POEMS syndrome. Yokouchi H, Baba T, Misawa S, Oshitari T, Kuwabara S, Yamamoto S. Br J Ophthalmol; 2020 Jan 15; 104(1):33-38. PubMed ID: 30914422 [Abstract] [Full Text] [Related]
17. Bevacizumab therapy for POEMS syndrome. Badros A, Porter N, Zimrin A. Blood; 2005 Aug 01; 106(3):1135. PubMed ID: 16033956 [No Abstract] [Full Text] [Related]
18. Clinical characteristics and the long-term outcome of patients with atypical POEMS syndrome variant with undetectable monoclonal gammopathy. He T, Zhao A, Zhao H, Cai H, Feng J, Zhang L, Cao X, Zhou D, Li J. Ann Hematol; 2019 Mar 01; 98(3):735-743. PubMed ID: 30612232 [Abstract] [Full Text] [Related]
19. An atypical presentation of POEMS syndrome with IgG kappa type M protein and normal VEGF level: Case report and review of literature. Pulivarthi S, Gurram MK. J Cancer Res Ther; 2018 Mar 01; 14(3):679-681. PubMed ID: 29893339 [Abstract] [Full Text] [Related]
20. Vascular endothelial growth factor as a predictive marker for POEMS syndrome treatment response: retrospective cohort study. Misawa S, Sato Y, Katayama K, Hanaoka H, Sawai S, Beppu M, Nomura F, Shibuya K, Sekiguchi Y, Iwai Y, Watanabe K, Amino H, Ohwada C, Takeuchi M, Sakaida E, Nakaseko C, Kuwabara S. BMJ Open; 2015 Nov 11; 5(11):e009157. PubMed ID: 26560063 [Abstract] [Full Text] [Related] Page: [Next] [New Search]